Lifemd, Inc. · NASDAQ:LFMD
Lifemd — Q4 2022 Earnings Presentation
9 slides from Lifemd's earnings presentation, March 2023
Slide 1: Supplemental Q4 2022 Presentation
Supplemental Q4 2022 Presentation March 2023
Slide 2: Important Cautions Regarding Forward-Looking Statements
Important Cautions Regarding Forward-Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private
Slide 3: Highlights: Q4/ FY 2022
Highlights: Q4/ FY 2022 Liquidity: Virtual Primary Care: Ended Q4’22 with $4M in cash The recently launched virtual primary care (VPC) platform ends Subsequent to quarter end, executed Debt Financing the year with approximately 7,000 patients. This is ahead agreement with major institutional investo
Slide 4: Early Mover Advantage, Supported By A Patient-Centric Approach, Has Enabled Incredible Growth
Early Mover Advantage, Supported $119M By A Patient-Centric Approach, Has Enabled Incredible Growth $93M $119M 2022A Revenue Forecast 28% $37M YoY Revenue Growth in ‘22 $13M 675K+ Patients & Customers To-Date 2019A 2020A 2021P 2022A 4 198% 149% 28%
Slide 5: Rapidly Accelerating Gross Margins And Increasing Leverage On Marketing Spend
Rapidly Accelerating Gross Margins And Increasing Leverage On Marketing Spend Driving Pathway To Profitability Consolidated Gross Margin % Marketing Cost as % of Sales 35 125% 90% 88% 32 100% Net Revenue ($ Millions) 86% 81% 77% 75% 72% 84% 29 75% 62% 82% 55% 80% 26 50% 78% 23 25% 76% 74% Q3 2021 Q4
Slide 6: Full Year 2023 Guidance Reflecting Substantial Profitability Growth
Full Year 2023 Guidance Reflecting Substantial Profitability Growth FY 2023 GUIDANCE FY 2022 ACTUAL DELTA % Consolidated Net Revenue $140-$150 million $119 million +18-26% Gross Margin % 87% 84% +300 bps Consolidated Adj. EBITDA $12-$18 million $(15) million +180-220% Free Cash Flow Break-Even Reach
Slide 7: Strong Liquidity to Meet our Capital and Growth Needs
Strong Liquidity to Meet our Capital and Growth Needs FY 2023 CASH FLOW GUIDANCE End of Year 2022 Actual Cash Balance $4 million Plus Avenue Capital FY23 Debt Proceeds, net +$18 million Operating Cash Flow (incl. Interest Expense) +$4-$8 million Less Capex $(6)-$(8) million Less Preferred Dividends
Slide 8: Key Take-aways
8 Key Take-aways Profitable, Growing Business: Achieved Adjusted EBITDA profitability in Q4 ’22 and nearly 30% annual revenue growth in FY 2022. Strong Liquidity: Following the execution of Avenue debt financing, significant dry powder to meet our growth and capital needs. Forecast to achieve Free C
Slide 9: Company Contact
Company Contact Marc Benathen [email protected]